NIH Common Fund's High Risk-High Reward Program:
New Funding Opportunity for the NIH Director's Transformative Research Award
Date: November 8, 2011
Time: 1:00-2:45 PM EST
Background
The NIH Director's High Risk-High Reward (HRHR) program, supported through the NIH Common Fund, was created to test new ways of stimulating the biomedical workforce by providing support for highly creative researchers and ideas that have the potential to fundamentally change the way we think about and conduct biomedical research. Four different NIH Director's awards comprise the HRHR program: the NIH Director's Transformative Research Award, Pioneer Award, New Innovator Award, and the Early Independence Award.
This informational webinar will provide information and answer questions about NEW funding opportunity announcements (FOAs) for the HRHR program, specifically for the Transformative Research Award http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-11-006.html, which is open until January 12, 2012 (5:00 PM local time of applicant organization). The types of questions to be addressed during the webinar include, but are not limited to:
· What types of projects have been funded to date?
· Why don't there seem to be so many clinical and/or behavioral science projects funded?
· What are the expectations regarding preliminary data?
· What are typical budgets of successful applications?
· What are the most common criticisms?
· What makes a particularly strong application?
· Can you give some examples of projects that might be considered transformative or not transformative?
· What is the review process?
· How are reviewers selected?
· How can applications with such diverse topic areas be reasonably reviewed by a single panel?
Agenda
1:00 PM Welcome
James Anderson, M.D., Ph.D., Director, Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI), NIH
1:05 PM New Funding Announcement for High Risk-High Reward Program:
NIH Director's Transformative Research Award
Ravi Basavappa, Ph.D., Program Director, Office of Strategic Coordination, DPCPSI, NIH
1:30 PM Review process for Transformative Research Award applications
John Bowers, Ph.D., Initial Review Group Chief and Scientific Review Officer for the
Transformative Research Award initiative, Center for Scientific Review, NIH
1:40 PM Question and Answer Session
Members of the High Risk-High Reward Working Group will answer questions submitted via Email and phone
2:45 PM Adjourn
Access the webinar via: https://webmeeting.nih.gov/hrhr
The computer system requirements for joining the webinar can be found here: http://webcollaboration.nih.gov/systemRequirements.asp
Please send us your questions in advance or during the program via Email at Transformative_Awards@mail.nih.gov or by phone at 1-800-593-9895, pass code 10699.
The webinar is open to external participants and NIH staff. The webinar is being broadcast from the NIH Bethesda campus, Bldg 31, 6C/7. In-person seating is limited. The webinar will be closed captioned and video archived on the Common Fund website (http://commonfund.nih.gov).
The NIH Common Fund (formerly the NIH Roadmap) encourages collaboration and supports a series of exceptionally high impact, trans-NIH programs. These programs are supported by the Common Fund, and managed by the NIH Office of the Director in partnership with the various NIH Institutes, Centers and Offices. Additional information about the NIH Common Fund can be found at http://commonfund.nih.gov.
----------------------
The National Institutes of Health (NIH) –"The Nation's Medical Research Agency" – includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.
The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services
TO UNSUBSCRIBE: send email to listserv@list.nih.gov, Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L in the message body of the email
- You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov 301-435-1309
No comments:
Post a Comment